SCHEMBL6096070

SCHEMBL6096070

CC#CS(=O)(=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.46
PSIP1 O75475 1/20 0.44
CA2 P00918 3/20 0.42
CA1 P00915 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CA12 O43570 1/20 0.42
CA3 P07451 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42
CA7 P43166 1/20 0.42
PLA2G7 Q13093 1/20 0.42
CA9 Q16790 1/20 0.42
CA13 Q8N1Q1 1/20 0.42
CA14 Q9ULX7 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15873589 0.80 HTR6 (0.50) HTR6PSIP1CA2CA1ALDH1A1
SCHEMBL13783355 0.79 GAA (0.52) CA2CA1ALDH1A1HSD17B10TDP1
SCHEMBL4388431 0.77 ALDH1A1 (0.44) HTR6PSIP1CA2CA1ALDH1A1
SCHEMBL8080302 0.77 ALDH1A1 (0.44) HTR6PSIP1CA2CA1ALDH1A1
SCHEMBL1482095 0.76 HTR6 (0.46) HTR6PSIP1CA2CA1ALDH1A1
SCHEMBL6548699 0.76 HTR6 (0.46) HTR6PSIP1CA2CA1ALDH1A1
SCHEMBL7948200 0.74 NPC1 (0.59) HTR6PSIP1CA2CA1ALDH1A1
SCHEMBL10656231 0.74 HTR6 (0.55) HTR6PSIP1CA2CA1ALDH1A1
SCHEMBL28766844 0.73 TSHR (0.44) HTR6PSIP1CA2CA1ALDH1A1
SCHEMBL7124034 0.72 HTR6 (0.52) HTR6PSIP1CA2CA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2197879-B1 C7-SUBSTITUTED CAMPTOTHECIN ANALOGS BIONUMERIK PHARMACEUTICALS INC (US) 2014-01-22 EP claimed
US-7101892-B2 Sulfone derivatives as 5-HT7 receptor ligands MERCK SHARP & DOHME LTD. 2006-09-05 US disclosed
US-20040229864-A1 Sulfone derivatives as 5-HT7 receptor ligands MERCK SHARP & DOHME LTD. (GB) 2004-11-18 US disclosed
US-4659727-A ANTIARTHRITIC AGENTS MAY & BAKER LIMITED (GB) 1987-04-21 US disclosed
EP-0174832-A2 Ethene derivatives MAY & BAKER LIMITED (GB) 1986-03-19 EP disclosed
US-4559082-A THIOCARBAMATES WITH UNSATURATED ARYL SULFIDES, SULFOXIDES OR SULFONES STAUFFER CHEMICAL CO. (US) 1985-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040229864-A1 Sulfone derivatives as 5-HT7 receptor ligands HTR7, HTR2C, HTR1A HTR6 14/4885PSIP1 1776/4885CA2 2094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.